Our understanding of PGRN-stimulated NFE2L2/ARE signaling not only characterizes the antioxidant role of PGRN under oxidative stress conditions but also provides new therapeutic interventions for PGRN in cervical cancer. Here, NFE2L2 is linked to cervical cancer.